drugset / Trial / NCT01764178

To Evaluate the Safety and PK Characteristics in Healthy Volunteers-Livalozet

NCT01764178

Phase 1 Completed 52 enrolled JW Pharmaceutical
RandomizedCrossoverOpen-labelOther

Summary

The purpose of this study is to compare pharmacokinetics between Pitavastatin and Valsartan co-administration and Livalo fixed combination drug in healthy male subjects.

Timeline

Start
2013-01-22
Primary completion
2013-03-15
Completion
2013-12-27

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pitavastatin Small molecule 4 mg
Comparator Valsartan Small molecule 160 mg